Abstract
High-grade or malignant glioma represent 10% of pediatric brain tumors and are, taken as a whole, the second more frequent malignant histotype after medulloblastoma. Apart from a complete excision followed by full dose local radiotherapy, chemotherapy seems to give some beneficial to final outcome. Different trials have explored the role of high-dose chemotherapy that theoretically could give an advantage to these patients by overcoming blood-brain barrier, tumor cell chemo-resistance and inducing a wider number of responses. It is, however, still doubtful if better responses translate into improved outcome and which patients can have a true beneficial from this treatment strategy.
Original language | English |
---|---|
Pages (from-to) | 641-643 |
Number of pages | 3 |
Journal | Pediatric Blood and Cancer |
Volume | 54 |
Issue number | 4 |
DOIs | |
Publication status | Published - Apr 2010 |
Keywords
- Anaplastic glioma
- Blood-brain barrier
- Glioblastoma
- High-dose chemotherapy
ASJC Scopus subject areas
- Oncology
- Pediatrics, Perinatology, and Child Health
- Hematology